Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2007 Jan;93(1):2-4.
doi: 10.1136/hrt.2006.089250.

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

N F Kelland, D J Webb
Editorial

Clinical trials of endothelin antagonists in heart failure: publication is good for the public health

N F Kelland et al. Heart. 2007 Jan.

Abstract

The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.

PubMed Disclaimer

Conflict of interest statement

Competing interests: NFK is a British Heart Foundation Junior Research Fellow (FS/03/006/15108) and has received grants to attend conferences from Merck, Pfizer and Sanofi. DJW has, in the past, advised Abbott, Actelion, Roche and Bristol‐Myers Squibb on the development of ET antagonists, and has undertaken clinical studies using ET antagonists with Astra‐Zeneca, Bristol‐Myers Squibb, Encysive, Takeda and Vanguard. NFK and DJW have received donations of ET antagonists from Abbott Pharmaceuticals for use in their preclinical research.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Davie N, Haleen S J, Upton P D.et al ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 2002165398–405. - PubMed
    1. Sato K, Oka M, Hasunuma K.et al Effects of separate and combined ETA and ETB blockade on ET‐1‐induced constriction in perfused rat lungs. Am J Physiol 1995269L668–L672. - PubMed
    1. MacLean M R, McCulloch K M, Baird M. Endothelin ETA‐ and ETB‐receptor‐mediated vasoconstriction in rat pulmonary arteries and arterioles. J Cardiovasc Pharmacol 199423838–845. - PubMed
    1. Attina T, Camidge R, Newby D E.et al Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 200591825–831. - PMC - PubMed
    1. Cannan C R, Burnett J C, Jr, Lerman A. Enhanced coronary vasoconstriction to endothelin‐B‐receptor activation in experimental congestive heart failure. Circulation 199693646–651. - PubMed

Publication types

Substances